Publications Preclinical activity of seribantumab in gastrointestinal cancers with NRG1 fusions April 10, 2021April 7, 2021 by Elevation Oncology Preclinical Diagnostics Genomic Testing Gene Fusions Data Research NRG1 fusion Partnership Virtual Poster Presentation Presenting Author: Igor Odintsov, MD; Memorial Sloan Kettering Cancer Center Save this Presentation Download PDF Share